Nefiracetam attenuates post-ischemic nonconvulsive seizures in rats and protects neuronal cell death induced by veratridine and glutamate.
Xi-ChunMay Lu, JitendraR Dave, Zhiyong Chen, Ying Cao, Zhilin Liao, FrankC Tortella
Index: Life Sci. 92(22) , 1055-63, (2013)
Full Text: HTML
Abstract
Stroke patients are at a high risk of developing post-ischemic seizures and cognitive impairment. Nefiracetam (NEF), a pyrrolidone derivative, has been shown to possess both anti-epileptic and cognitive-enhancing properties. In this study the anti-seizure effects of NEF were evaluated in a rat model of post-ischemic nonconvulsive seizures (NCSs). Its potential mechanisms were investigated in neuronal cell culture assays of neurotoxicity associated with ischemic brain injury and epileptogenesis.
Related Compounds
Related Articles:
2005-09-01
[Arch. Toxicol. 79(9) , 500-7, (2005)]
2009-05-05
[Neuroscience 160(2) , 484-91, (2009)]
2005-06-01
[Epilepsia 46(6) , 811-8, (2005)]
Negative regulation of opioid receptor-G protein-Ca2+ channel pathway by the nootropic nefiracetam.
2004-10-01
[Ann. N. Y. Acad. Sci. 1025 , 389-97, (2004)]
Nefiracetam, a novel cognition-enhancing agent. An introductory overview.
1994-02-01
[Arzneimittelforschung 44(2A) , 193-4, (1994)]